Type 2 & other diabetes

Association of Serum Albumin-to-globulin Ratio (AGR) With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

AGR is a promising biomarker in risk predictions for long-term mortality in diabetic individuals, particularly in those younger than 60 years and heavy drinkers.

Study context

Population
Adults with diabetes, National Health and Nutrition Examination Survey (NHANES) 1999–2018, mortality linked to National Death Index through December 31, 2019
Participants
8,508 adults
Exposure
Highest vs lowest serum AGR quartile
Outcome
All-cause, CVD and cancer mortality
Follow-up
Average 9.61 years
Methodological detailsNHANES 1999–2018, weighted Cox proportional-hazards models, multivariate-adjusted
  • NHANES 1999–2018
  • Weighted Cox proportional-hazards models
  • Multivariate-adjusted

Main finding

As reported in the abstract

Mortality, highest AGR quartile
Estimate (95% CI)P value
Highest AGR quartile
multivariate-adjusted HR, all-cause mortality 0.51(0.42–0.60)
P < 0.0001for trend
Highest AGR quartile
multivariate-adjusted HR, CV mortality 0.62(0.46–0.83)
P < 0.001for trend
Highest AGR quartile
multivariate-adjusted HR, cancer mortality 0.57(0.39–0.85)
P < 0.01for trend
All-cause deaths
2415
CV deaths
688
Cancer deaths
413

Observational data: associations, not effects.

Further findings

Mortality per 1-unit rise in natural log-transformed serum AGR

Decreased risk of all-cause death
73%
Decreased risk of cardiovascular disease (CVD) mortality
60%
Decreased risk of cancer mortality
63%
  • All P < .001

Stratified and sensitivity analyses

Same relationships in stratified and sensitivity analyses

Original publication

Association of Serum AGR With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes. J Clin Endocrinol Metab. Published 4 April 2024. doi:10.1210/clinem/dgae215

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.